STAT5B and acute lymphoblastic leukemia: We data-mined 8 independent studies with sequencing data from 1,234 patients with T-ALL (4, 11, 24, 25, 32–35) and found that a mean of 3.8% (0.6%–12.9%) of patients harbored STAT5B mutations (Figure 1A).